Login Register Cart 0
Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Sedation with Ketamine-Propofol in Patients Undergoing Transcatheter Aortic Valve Implantation: A Comparative Retrospective Study on General Anesthesia

Author(s): Nurdan Yilmaz*, Yasar Gokhan Gul and Murat Ugurlucan

Volume 22, Issue 4, 2024

Published on: 25 January, 2024

Page: [266 - 272] Pages: 7

DOI: 10.2174/0115701611274790231221044147

Price: $65

Abstract

Background: Transcatheter aortic valve implantation (TAVI) is used for patients with severe aortic stenosis who are at high risk for surgery. Since these patients are elderly and have comorbidities, their management is of great importance.

Objectives: This retrospective study compares two anesthesia techniques during TAVI: sedation (ketamine and propofol) and general anesthesia.

Methods: Patients with severe aortic stenosis undergoing TAVI during 2021 in our hospital were retrospectively screened. Demographic data, comorbidities, anesthesia management, complications, and mortality of the patients were obtained from the records.

Results: There were 137 patients treated with TAVI; 74 (54%) patients had sedation and 63 (46%) had general anesthesia. When the anesthesia management was evaluated, no significant difference in mortality was observed between the patients who received general anesthesia and sedation. After univariate and multivariate logistic regression analyses were performed to investigate factors having an impact on mortality, anemia (only in univariate analysis) in the whole study population was a statistically significant risk factor for mortality in patients undergoing TAVI (p<0.014).

Conclusion: There was no significant difference in mortality in terms of anesthesia management. Anemia was a risk factor for mortality (only in univariate analysis) in the whole study population. We concluded that conscious sedation with ketamine and propofol is effective and safe for TAVI procedures compared to general anesthesia.

Keywords: Transcatheter aortic valve implantation (TAVI), general anesthesia, sedation, ketamine, propofol, severe aortic stenosis.

« Previous Next »
Graphical Abstract

[1]
Thiele H, Kurz T, Feistritzer HJ, et al. General versus local anesthesia with conscious sedation in transcatheter aortic valve implantation. Circulation 2020; 142(15): 1437-47.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.120.046451] [PMID: 32819145]
[2]
Kim YY, Heo HJ, Lee JH, Cho HG, Kim G. Assessing the safety of total intravenous anesthesia with remimazolam in general anesthesia for transcatheter aortic valve implantation of severe aortic valve stenosis: A case series. Medicina 2022; 58(11): 1680.
[http://dx.doi.org/10.3390/medicina58111680] [PMID: 36422219]
[3]
Wang L, Liu Y, Gao H, et al. Comparison of safety and effectiveness of local or general anesthesia after transcatheter aortic valve implantation: A systematic review and meta-analysis. J Clin Med 2023; 12(2): 508.
[http://dx.doi.org/10.3390/jcm12020508] [PMID: 36675437]
[4]
Fröhlich GM, Lansky AJ, Webb J, et al. Local versus general anesthesia for transcatheter aortic valve implantation (TAVR) – systematic review and meta-analysis. BMC Med 2014; 12(1): 41.
[http://dx.doi.org/10.1186/1741-7015-12-41] [PMID: 24612945]
[5]
Erkan G, Ozyaprak B, Kaya FA, Dursun İ, Korkmaz L. Comparison of anesthesia management in transcatheter aortic valve implantation: a retrospective cohort study. Braz J Anesthesiol 2022; 72(5): 629-36.
[http://dx.doi.org/10.1016/j.bjane.2021.06.017] [PMID: 34252453]
[6]
Rudolph TK, Messika-Zeitoun D, Frey N, et al. Impact of selected comorbidities on the presentation and management of aortic stenosis. Open Heart 2020; 7(2): e001271.
[http://dx.doi.org/10.1136/openhrt-2020-001271] [PMID: 32709699]
[7]
Lindman BR, Pibarot P, Arnold SV, et al. Transcatheter versus surgical aortic valve replacement in patients with diabetes and severe aortic stenosis at high risk for surgery: an analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve). J Am Coll Cardiol 2014; 63(11): 1090-9.
[http://dx.doi.org/10.1016/j.jacc.2013.10.057] [PMID: 24291272]
[8]
Ben-Dor I, Looser PM, Maluenda G, et al. Transcatheter aortic valve replacement under monitored anesthesia care versus general anesthesia with intubation. Cardiovasc Revasc Med 2012; 13(4): 207-10.
[http://dx.doi.org/10.1016/j.carrev.2012.02.002] [PMID: 22818531]
[9]
Bracken-Clarke D, Segurado R, Barry M, et al. Is local anesthesia the optimum strategy in retrograde transcatheter aortic valve implantation? A systematic review and meta-analysis. Thorac Cardiovasc Surg 2014; 62(6): 489-97.
[http://dx.doi.org/10.1055/s-0034-1383721] [PMID: 25083832]
[10]
Yamamoto M, Meguro K, Mouillet G, et al. Effect of local anesthetic management with conscious sedation in patients undergoing transcatheter aortic valve implantation. Am J Cardiol 2013; 111(1): 94-9.
[http://dx.doi.org/10.1016/j.amjcard.2012.08.053] [PMID: 23068861]
[11]
Brecker SJD, Bleiziffer S, Bosmans J, et al. Impact of anesthesia type on outcomes of transcatheter aortic valve implantation (from the Multicenter ADVANCE Study). Am J Cardiol 2016; 117(8): 1332-8.
[http://dx.doi.org/10.1016/j.amjcard.2016.01.027] [PMID: 26892451]
[12]
Goel R, Power D, Tchetche D, et al. Impact of diabetes mellitus on short term vascular complications after TAVR: Results from the BRAVO-3 randomized trial. Int J Cardiol 2019; 297: 22-9.
[http://dx.doi.org/10.1016/j.ijcard.2019.09.063] [PMID: 31630816]
[13]
Abushouk AI, Abdelfattah OM, Hassanein M, et al. Transcatheter aortic valve implantation outcomes in chronic kidney disease versus end-stage kidney disease. Am J Cardiol 2021; 143: 165-7.
[http://dx.doi.org/10.1016/j.amjcard.2021.01.002] [PMID: 33453172]
[14]
Razuk V, Camaj A, Cao D, et al. Impact of anemia on short‐term outcomes after TAVR: A subgroup analysis from the BRAVO ‐3 randomized trial. Catheter Cardiovasc Interv 2021; 98(6): E870-80.
[http://dx.doi.org/10.1002/ccd.29753] [PMID: 33909348]
[15]
Nicolas J, Claessen BE, Cao D, et al. Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN‐TAVI registry. Catheter Cardiovasc Interv 2021; 97(5): E704-15.
[http://dx.doi.org/10.1002/ccd.29276] [PMID: 33002302]
[16]
Azizoğlu M, Ozdemi L, Ozkan B, Doruk N. Transkateter aortik valv implantasyonu işleminde anestezi deneyimlerimiz. Anestezi Dergisi 2018; 26(3): 164-8.
[17]
Melidi E, Latsios G, Toutouzas K, et al. Cardio-anesthesiology considerations for the trans-catheter aortic valve implantation (TAVI) procedure. Hellenic J Cardiol 2016; 57(6): 401-6.
[http://dx.doi.org/10.1016/j.hjc.2016.10.001] [PMID: 28375080]
[18]
Totonchi Z, Alizadehasl A, Sadeghpour A, Azarfarin R, Rahimi S, Hendiani A. Comparison of sedation between dexmedetomidine and propofol during transesophageal echocardiography: A randomized controlled trial. Ann Card Anaesth 2019; 22(3): 285-90.
[http://dx.doi.org/10.4103/aca.ACA_42_18] [PMID: 31274491]
[19]
Sruthi S, Mandal B, Rohit MK, Puri GD. Dexmedetomidine versus ketofol sedation for outpatient diagnostic transesophageal echocardiography: A randomized controlled study. Ann Card Anaesth 2018; 21(2): 143-50.
[PMID: 29652275]
[20]
El Mourad MB, Shaaban AE, El Sharkawy SI, Afandy ME. Effects of propofol, dexmedetomidine, or ketofol on respiratory and hemodynamic profiles in cardiac patients undergoing transesophageal echocardiography: A prospective randomized study. J Cardiothorac Vasc Anesth 2021; 35(9): 2743-50.
[http://dx.doi.org/10.1053/j.jvca.2020.11.013] [PMID: 33262033]
[21]
Villablanca PA, Mohananey D, Ramakrishna H. Comparison of local versus general anesthesia in patients undergoing transcatheter aortic valve replacement: An updated meta‐analysis. Catheter Cardiovasc Interv 2018; 92(5): 1018-9.
[http://dx.doi.org/10.1002/ccd.27639] [PMID: 29659154]
[22]
Eskandari M, Aldalati O, Dworakowski R, et al. Comparison of general anaesthesia and non-general anaesthesia approach in transfemoral transcatheter aortic valve implantation. Heart 2018; 104(19): 1621-8.
[http://dx.doi.org/10.1136/heartjnl-2017-312559] [PMID: 29599379]
[23]
Herrmann HC, Cohen DJ, Hahn RT, et al. Utilization, costs, and outcomes of conscious sedation versus general anesthesia for transcatheter aortic valve replacement. Circ Cardiovasc Interv 2021; 14(7): e010310.
[http://dx.doi.org/10.1161/CIRCINTERVENTIONS.120.010310] [PMID: 34130476]
[24]
Husser O, Fujita B, Hengstenberg C, et al. Conscious sedation versus general anesthesia in transcatheter aortic valve replacement. JACC Cardiovasc Interv 2018; 11(6): 567-78.
[http://dx.doi.org/10.1016/j.jcin.2017.12.019] [PMID: 29566803]
[25]
Hyman MC, Vemulapalli S, Szeto WY, et al. Conscious sedation versus general anesthesia for transcatheter aortic valve replacement. Circulation 2017; 136(22): 2132-40.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.116.026656] [PMID: 28864443]
[26]
Mosleh W, Mather JF, Amer MR, Hiendlmayr B, Kiernan FJ, McKay RG. Propensity matched analysis comparing conscious sedation versus general anesthesia in transcatheter aortic valve implantation. Am J Cardiol 2019; 124(1): 70-7.
[http://dx.doi.org/10.1016/j.amjcard.2019.03.042] [PMID: 31064667]
[27]
Mayr NP, Michel J, Bleiziffer S, Tassani P, Martin K. Sedation or general anesthesia for transcatheter aortic valve implantation (TAVI). J Thorac Dis 2015; 7(9): 1518-26.
[PMID: 26543597]
[28]
Harjai KJ, Bules T, Berger A, et al. Transcatheter interventions at geisinger structural (tigers) registry, geisinger health system, pennsylvania. Efficiency, safety, and quality of life after transcatheter aortic valveimplantation performed with moderate sedation versus general anesthesia. Am J Cardiol 2020; 125(7): 1088-95.
[http://dx.doi.org/10.1016/j.amjcard.2020.01.002] [PMID: 32046822]

Rights & Permissions Print Cite
Article Metrics
24
1
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy